Round Versus Anatomical Implants in Breast Reconstruction: A Systematic Review and Meta-analysis Authors: Daniel Correia, Gauthier Zinner, Jérôme Martineau, Carlo M. Oranges Published: 2026 ABSTRACT Background:Implant-based breast reconstruction (IBBR) is the most commonly used technique for oncological breast reconstruction. Implants vary in size, composition, texture, and shape. Numerous studies have attempted to determine whether the postoperative outcomes differ based on the shape of the implant, the 2 most common being round and anatomical implants. This systematic review and comparative meta-analysis evaluates postoperative outcomes and aesthetic satisfaction following IBBR with round or anatomical implants.Methods:A systematic review of the literature and comparative meta-analysis were performed to assess the differences in complication rates, patient-reported outcomes, and aesthetic satisfaction between patients undergoing IBBR with round or anatomical implants. Only comparative studies reporting on postoperative complications or patient-reported outcomes following IBBR were included. Odds ratios and 95% confidence intervals (95% CIs) were calculated using a random-effects model.Results:Nine studies were included, representing 2535 patients, with 1578 patients and 957 patients in the round and anatomical implant groups, respectively. No difference was observed in the overall complication rate between the round and anatomical implant groups (odds ratio = 0.46; 95% CI = 0.14–1.48; P = 0.19). Specific complication rates and patient-reported outcomes were also similar across groups.Conclusions:In IBBR, round or anatomical implants have similar complication rates and aesthetic results. The choice of implant type should therefore be made through shared decision-making, guided by the surgeon’s experience, the patient’s morphology, and personal preference to achieve optimal results. Takeaways Question: Does the type of implant influence complications and aesthetic satisfaction in the context of implant-based breast reconstruction? Findings: Our meta-analysis included 9 comparative studies representing 2535 patients. We found that implant shape did not make a difference in complication rates or levels of patient satisfaction. Meaning: Implants should be chosen based on the patient’s chest anatomy, their desires for aesthetic outcome, and the surgeon’s experience with the different implant types. INTRODUCTION Breast reconstruction after mastectomy allows improvement of women’s body image, psychological well-being, and overall quality of life.1,2 Implant-based breast reconstruction (IBBR) is the most commonly performed type of breast reconstruction due to its relative simplicity, shorter operative time, and avoidance of donor-site morbidity compared with autologous reconstruction.2–6 As techniques and materials have evolved, different implant types have emerged, including round and anatomical implants, also called shaped implants.7–9 Round implants are symmetrical, and some surgeons prefer these due to a perceived lower risk of implant malrotation or malposition and their lower cost.10,11 In comparison, anatomical implants are designed to mimic the natural contour of the breast, which is described as a “drop”-like shape, potentially leading to superior aesthetic outcomes.3,12 However, they have a higher cost and are associated with a risk of implant rotation that may compromise the aesthetic outcome.10,11,13,14 Unlike breast augmentation, breast reconstruction following mastectomy involves the removal of glandular structures, resulting in a larger dead space, which can increase the risk of implant malposition and unaesthetic outcomes.15 This is why numerous studies have explored which implant type is most suitable for breast reconstruction. However, findings remain inconsistent and often limited by small sample sizes and the retrospective nature of the studies, leading to highly heterogeneous literature on this topic.9,12,16,17 This systematic review and meta-analysis compares postoperative outcomes, complication rates, and aesthetic satisfaction in patients undergoing IBBR with round versus anatomical implants. METHODS This systematic review was conducted using PubMed/MEDLINE, Embase, and the Cochrane Library following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines as of November 15, 2024.18 The study protocol was registered in advance on PROSPERO (registration ID: CRD42024607790). A comprehensive search strategy was developed, using a combination of keywords and synonyms for “implant-based breast reconstruction,” “round prosthesis,” and “anatomic prosthesis,” connected through Boolean operators (Table 1). Table 1.Search StrategyKeywordsDatabasesNo. Articles(“implant-based breast reconstruction” OR (“implant based” AND (“breast”/exp OR breast) AND (“reconstruction”/exp OR reconstruction)) OR “breast reconstruction”/exp OR “breast reconstruction” OR ((“breast”/exp OR breast) AND (“reconstruction”/exp OR reconstruction))) AND (shaped OR anatomic) AND (“prosthesis”/exp OR prosthesis OR “implant”/exp OR implant) AND roundPubMed185Embase106Cochrane Library4(((implant-based breast reconstruction) OR (breast reconstruction)) AND (((prosthesis) OR (implant)) AND ((shaped) OR (anatomic))) AND ((prosthesis) OR (implant)) AND (round))Web of Science54 Search Strategy Study Eligibility and Selection Process The review process began with the definition of inclusion and exclusion criteria based on the PICOS (population, intervention, comparison, outcome, and study design) framework (Table 2). The analysis included retrospective and prospective comparative studies evaluating adult female patients who underwent immediate or delayed IBBR with round or anatomical prostheses or expanders. Studies that focused on other breast reconstruction techniques, such as autologous breast reconstruction, were excluded. The primary outcome was to compare postoperative complication rates and aesthetic satisfaction associated with IBBR with round prostheses compared with anatomical prostheses. Studies not reporting on the primary outcomes, as well as case reports, case series, systematic reviews, meta-analyses, letters, and conference abstracts, were excluded. Only studies published in English were eligible. No restrictions regarding the time of publication were applied. All identified articles were processed through the Rayyan platform (https://www.rayyan.ai/; accessed November 15, 2024) to enable independent, blinded screening by 2 reviewers (D.C. and G.Z.).19 The screening process involved an initial review of titles and abstracts by the same 2 authors (D.C. and G.Z.), with discrepancies resolved through consultation with the senior author (C.M.O.). Table 2.PICOS-based Selection CriteriaPICOSInclusion CriteriaExclusion CriteriaPopulationAdult female patientsCadaver, animal, or experimental models; patients younger than 18 y oldInterventionIBBR after mastectomyOther types of reconstruction; other indications for surgery such as purely aesthetic reconstruction or breast augmentationComparatorPatient with round or anatomic/anatomical/shaped implantOutcomesRound and anatomical/shaped implants; patient satisfaction and aesthetic outcomes evaluated with BREAST-Q scoreStudies not reporting complications and/or BREAST-Q scoresStudiesComparative, prospective, and retrospective studiesCase reports, case series, abstract only, letters, reviews, and comments PICOS-based Selection Criteria Data Collection and Outcome Measures Two reviewers (D.C. and G.Z.) independently extracted data from eligible studies, focusing on study design, demographic characteristics, and clinical outcomes. Extracted data were compiled into an Excel spreadsheet (version 16.91, 2024 Microsoft, Redmond, WA) and cross-referenced to ensure accuracy. For each study, demographic data, intraoperative variables, postoperative complication rates, and BREAST-Q scores were collected. The BREAST-Q is a breast surgery–specific patient-reported outcome measure with 6 domains: physical, psychosocial, and sexual well-being; satisfaction with breasts; overall outcomes; and process of care.20 Postoperative complications included overall complications, implant loss, hematoma, seroma, infection, implant rupture, implant exposure, implant displacement, nipple–areolar complex (NAC) necrosis, capsular contracture, implant asymmetry, and revision surgery rate. Patient-reported outcomes were assessed as a secondary outcome with the BREAST-Q. Items reported in fewer than 3 articles were not included. Statistical Analysis Approach The meta-analysis was performed using Review Manager 5.4.1 software (The Cochrane Collaboration, The Nordic Cochrane Center, Copenhagen, Denmark). The pooled odds ratios (ORs) for comparative outcomes were calculated using the Mantel–Haenszel method with a random-effects model to address interstudy variability. For the outcomes evaluated with the BREAST-Q score, due to the continuous nature of the variable, the mean differences (MD) were calculated using the inverse variance method with a random-effects model. Heterogeneity among the studies was assessed using the I2 statistic and the Q statistic P value. An I2 value of less than 30% was indicative of low heterogeneity, whereas values greater than 70% reflected substantial heterogeneity.21 Results were summarized in forest plots, presenting ORs along with 95% confidence intervals (95% CI). In 1 study, medians and interquartile ranges were estimated as means and 95% CIs using the method of Luo et al22 and Higgins and Deeks,23 respectively.24 For another study,25 the SDs of the BREAST-Q scores were estimated using the method described by Higgins and Deeks,23 based on the number of participants “n” and the 95% CI, with an adjustment for small groups (n < 60) for this study. Statistical significance was set at a P value of less than 0.05. Quality Assessment The quality of nonrandomized studies included in the meta-analysis was evaluated using the Newcastle-Ottawa Scale (NOS). Studies scoring 8–9 points were deemed to have a strong design, effective confounder control, and reliable outcome reporting, signifying a low risk of bias.26 (See table, Supplemental Digital Content 1, which shows the NOS, https://links.lww.com/PRSGO/F54.) RESULTS A total of 349 studies were identified across multiple databases (Fig. 1). After suppressing duplicates and screening based on title and abstract, 26 studies were reviewed in full text to assess eligibility. Nine studies met all inclusion criteria15,24,25,27–32 (Table 2). A total of 2535 patients across the included studies were analyzed and divided into 2 groups based on the type of implant used, either round or anatomical, resulting in 1578 patients in the round implant cohort, representing 2525 round implant breast reconstructions, and 957 patients in the anatomical implant cohort, representing 1467 anatomical implant breast reconstructions (Table 3). When the reconstruction technique involved a temporary breast expander, patients were categorized based on the shape of the final implant used for the reconstruction. The mean age ranged between 45.3 and 54.8 years in the round implant group and 42.2 and 53.3 years in the anatomical implant group. Details on other demographic and baseline characteristics can be found in Supplemental Digital Contents 2 and 3. (See table, Supplemental Digital Content 2, which shows study and patient characteristics, https://links.lww.com/PRSGO/F55.) (See table, Supplemental Digital Content 3, which shows operative characteristics of included studies, https://links.lww.com/PRSGO/F56.) The reconstructions were mostly bilateral in both groups, with a higher proportion of bilateral reconstructions among patients in the round group (947 [60.0%] patients) compared with the anatomical group (510 [53.3%] patients) (P = 0.014). Table 3.Patient and Operative CharacteristicsRoundAnatomical/ShapedNo. Studies Reporting DataPatients, n15789579Breast, n252514679Active smokers, n57286HTN, n46244Diabetes, n2394Previous radiotherapy, n83556Unilateral, n6314479Bilateral, n9475109Single-stage BR, n2412846*Second-stage BR, n1881236*Prepectoral, n61†24†4Retropectoral, n123†188†4Prophylactic, n109332Therapeutic, n8043402*One more study (7 total) reports data but only “per breast” basis.†Data reported per breast. Patient and Operative Characteristics One more study (7 total) reports data but only “per breast” basis. Data reported per breast. PRISMA 2020 flow diagram for new systematic reviews that included searches of databases and registers only. No significant statistical difference in the overall complication rate was observed between the 2 groups (OR = 0.46; 95% CI = 0.14–1.48; P = 0.19) (Fig. 2). Similarly, the complication rates of the specific complications such as seroma (OR = 1.31; 95% CI = 0.61–2.84; P = 0.49) (Fig. 3), hematoma (OR = 2.12; 95% CI = 0.28–15.90; P = 0.46) (Fig. 4), infection (OR = 0.67; 95% CI = 0.24–1.87; P = 0.45) (Fig. 5), NAC necrosis (OR = 0.75; 95% CI = 0.21–2.66; P = 0.66) (Fig. 6), implant loss (OR = 0.57; 95% CI = 0.24–1.34; P = 0.20) (Fig. 7), implant rupture (OR = 1.39; 95% CI = 0.23–8.47; P = 0.72) (Fig. 8), implant exposure (OR = 0.75; 95% CI = 0.47–1.19; P = 0.22) (Fig. 9), capsular contracture (OR = 1.22; 95% CI = 0.68–2.18; P = 0.51) (Fig. 10), and implant asymmetry (OR = 1.51; 95% CI = 0.47–4.87; P = 0.49) (Fig. 11) were not statistically significantly different between groups. In addition, the revision surgery rate did not differ across groups (OR = 1.40; 95% CI = 0.85–2.29; P = 0.18) (Fig. 12). Overall complications in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Seroma events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Hematoma events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Infection events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. NAC necrosis events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Implant loss events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Implant rupture events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Implant exposure events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Capsular contracture events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Implant asymmetry events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Revision surgery events in round vs anatomical/shaped implants. M-H, Mantel-Haenszel. Based on the reported data, only 4 items of the BREAST-Q could be evaluated, including the physical well-being (MD = −2.83; 95% CI = −7.96 to 2.30; P = 0.28) (Fig. 13), sexual well-being (MD = 2.98; 95% CI = −0.11 to 6.08; P = 0.06) (Fig. 14), postoperative satisfaction (MD = 6.80; 95% CI = −2.56 to 16.16; P = 0.15) (Fig. 15), and psychosocial well-being (MD = 4.46; 95% CI = −0.27 to 9.20; P = 0.06) (Fig. 16). None of them showed a significant difference. Even though the BREAST-Q is a validated tool, the response rate of the participants is often low. A summary of the BREAST-Q response rate of the included studies can be found in Supplemental Digital Content 4. (See table, Supplemental Digital Content 4, which shows BREAST-Q response rate, https://links.lww.com/PRSGO/F57.) BREAST-Q scores: physical well-being—round vs anatomical/shaped implants. IV, inverse variance; M-H, Mantel-Haenszel. BREAST-Q scores: sexual well-being—round vs anatomical/shaped implants. IV, inverse variance; M-H, Mantel-Haenszel. BREAST-Q scores: postoperative satisfaction—round vs anatomical/shaped implants. IV, inverse variance; M-H, Mantel-Haenszel. BREAST-Q scores: psychosocial well-being—round vs anatomical/shaped implants. IV, inverse variance; M-H, Mantel-Haenszel. To interpret the quality and reliability of each study included, we scored them according to the NOS. Three studies had high scores (8–9 points),25,27,31 5 had an average score of 7 points,15,24,29,30,32 and 1 had a low score of 4 points.28 We defined an adequate follow-up time as a follow-up period of 5 years to assess complications requiring a long exposure time, such as capsular contractures, 75% of which occur within 2 years, according to the American Society of Plastic Surgeons.33 Only 5 of the studies reported a precise follow-up time (Table 4).15,25,27,28,32 All studies, except for the study by Caplin31 had a mean follow-up less than 5 years, and most did not address the subjects lost to follow-up (Supplemental Digital Content 1, https://links.lww.com/PRSGO/F54). Table 4.Mean Patient Follow-up TimeAuthorsFollow-up Time (mo), Mean (SD/Range)Round, nShaped, nBuonomo et al258.2 ± 5.110.8 ± 7.2Imahiyerobo et al2924 ±*12 ±*Jeon et al3215.1 ± 8.728.6 ± 19.5Agochukwu-Nwubah et al2415 (12–42)†Khavanin et al1518.5 ± 2.318.3 ± 2.4Nahabedian288.7 ± 3.07.7 ± 4.2Macadam et al27R: 25 (12–48)‡R: 20 (12–62)‡NR: 25.5 (12 ± 48)‡NR: 26 (8–89)‡Dorfman et al309.7 (1–31.3)†Caplin31108 (70% follow-up rate)§108 (64% follow-up rate)§*Not available.†Range indicated when SD not available.‡Median (range) reported when mean and SD not available.§Follow-up rate (%) from 9-year clinical trial.NR, BREAST-Q nonresponders; R, BREAST-Q responders. Mean Patient Follow-up Time Not available. Range indicated when SD not available. Median (range) reported when mean and SD not available. Follow-up rate (%) from 9-year clinical trial. NR, BREAST-Q nonresponders; R, BREAST-Q responders. DISCUSSION IBBR uses either round or anatomical implants, and each has its own advantages, disadvantages, and technical considerations.2 Few studies have assessed which type of implant yields the best postoperative outcomes and patient satisfaction after breast reconstruction. Our analysis showed no significant difference between round and anatomical implants in terms of overall complication rate, as observed in previous studies.15,24,27,31,34–36 Similarly, there were no significant differences in specific postoperative complications between the 2 groups, including the rate of seroma, hematoma, infection, NAC necrosis, implant loss, implant rupture, implant exposure, or implant asymmetry. A previous meta-analysis by Han et al37 found a lower rate of implant rupture or rippling in patients with anatomical prostheses. However, the authors only included 2 studies analyzing implant rippling and 3 analyzing implant rupture, corresponding to 309 and 1502 patients, respectively. This represents a smaller population than that included in the present study (2382 implant ruptures), with insufficient statistical power. In addition, a number of factors were not considered and could contribute to the pathogenesis of these complications. Indeed, risk factors for implant ruptures included long interval between the first- and second-stage operations, implant age, manufacturer, breast trauma before surgery, and implant reconstruction ipsilateral to the dominant limb.38,39 It also appears that the latest-generation prostheses demonstrate a reduced risk of rupture.40 Our results, although plausible, must therefore also be confirmed in the light of the above-mentioned factors. In the present evaluation, the included studies did not report implant rippling rates consistently, which prevents us from analyzing this element. Articles in this systematic review and meta-analysis included only textured anatomical implants and smooth round implants. Our analysis aimed to evaluate the impact of the implant’s shape on postoperative outcomes and patient satisfaction only. However, the frequent association between implant shape and surface type or texture makes it challenging to determine whether the observed outcomes are attributable to the shape itself or to the associated texture. Previous studies showed a similar rate, whereas others showed a lower capsular contracture rate with smooth round prostheses.15,24,31,33 A meta-analysis by Liu et al41 showed that textured implants had a significantly lower rate of capsular contracture, demonstrating the involvement of the surface in its pathogenesis.42,43 Indeed, the 2 main theories on the genesis of capsular contractures suggest the involvement of bacterial biofilm formation and chronic inflammation leading to fibrosis.44 Experimental studies have shown that a rougher textured implant is associated with biofilm formation due to the larger surface area compared with round implants, which contradicts previous observations.45,46 Furthermore, although macrotextured implants are likely to harbor more biofilm, we did not find a difference in overt infection rates between the 2 types of implants. On the contrary, previous studies have shown that smooth implants present a greater infection risk.47 However, the authors point out that these differences may be attributable to underlying risk factors, which include high body mass index, diabetes, smoking status, postmenopausal status, prior breast surgery, steroid use, lymph node resection, and neoadjuvant chemotherapy or radiotherapy.48 In our analysis, we observed no difference in infection rates between smooth round and textured anatomical implant breast reconstructions. Conversely, Han et al37 reported in their meta-analysis a lower infection rate with smooth round implants. However, there is a lack of standardization in many factors involved in the pathogenesis or in the techniques used to reduce infections. Furthermore, the authors stated that the limited follow-up time may have led to underreporting of certain complications, including infections.37 In fact, their analysis included 1614 cases compared with the 3380 cases in the present study, which likely provided greater statistical power. Nevertheless, despite infection being considered the main cause of capsular contracture, the data extracted from the included studies were not comprehensive enough to make any conclusive statement on the rate of capsular contracture in the 2 groups, even if the infection rate was similar.44 Anatomical prostheses were developed to provide a better upper pole projection, initially suggesting a more aesthetic result.49 Numerous studies have attempted to compare aesthetic results between round and anatomical prostheses. The current consensus is that there is no superiority of one type over the other.50 However, few studies have objectively reported aesthetic results using a standardized tool such as the BREAST-Q. No significant differences were observed among the BREAST-Q items analyzed in our study, that is, postoperative satisfaction (Fig. 15) and physical (Fig. 13), sexual (Fig. 14), and psychosocial well-being (Fig. 16). Current literature supports our findings on the lack of superiority of either implant shape in providing a greater aesthetic outcome or satisfaction.9,15,24,27,31,35,36 Nevertheless, Buonomo et al25 found that patients who underwent breast reconstruction with round implants reported higher postoperative satisfaction and psychosocial well-being, whereas patients who had reconstructive surgery performed with anatomical implants reported higher physical well-being. These results could be biased by the fact that most patients who had breast reconstruction using anatomical implants underwent unilateral reconstruction, whereas the majority of patients in the round prosthesis group underwent bilateral reconstruction and obtained a higher symmetry rate.25 Moreover, research on implant type selection for oncological breast reconstructions is limited. Most available recommendations are based on breast augmentation rather than oncological breast reconstructions, where consensus is lacking.51 Implant type selection could be based on chest wall anatomy and potential deformities, the patient’s preoperative breast anatomy, the patient’s preferences, and the breast skin quality.36,52–57 Textured implants are associated with the development of breast implant–associated anaplastic large cell lymphoma. Appropriate patient education and consideration of smooth-surface implants are critical.58–61 Study limitations include heterogeneity of the study populations, relatively short patient follow-up (Table 4) that may have falsely reduced rates of capsular contracture and other complications, the absence of patient randomization or blinding, and potential patient selection bias.33 However, when evaluating the outcomes of oncological IBBR with different implant shapes, this meta-analysis includes the largest cohort of cases and is based on the most recent available data. CONCLUSIONS This systematic review and meta-analysis showed that oncological IBBR with either round or anatomical implants can be performed safely with comparable postoperative complication rates and patient-reported outcomes. No significant difference in overall complications, specific breast complications, or BREAST-Q scores for aesthetic satisfaction or physical, psychological, and sexual well-being domains was found. Our findings suggest that there is no clear advantage of one implant type over the other, although further large randomized comparative studies are warranted to confirm these findings. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. Supplementary Material